Receive our newsletter – data, insights and analysis delivered to you
  1. News
May 19, 2021

Elligo Health and Laguna Clinical partner to boost trials access

Elligo Health Research and Laguna Clinical Research Associates partner to expand access to clinical trials.

Elligo Health Research has partnered with Laguna Clinical Research Associates (LCRA) to expand access to clinical trials in diverse communities.

The partners will collaborate with more than 20 urgent care locations in these communities. Laguna will deliver medical services and clinical research as a care option to varied patient populations via Elligo.

Elligo and Laguna aim to connect clinical experts with research infrastructure to offer a clinical trial execution solution that will enable better patient access and engagement.

The new model will work with healthcare providers and patients to increase resources and provide direct access to eSource data from clinical sites.

Laguna Clinical Research Associates CEO Dr Veronica Procasky said: “Partnering with Elligo allows us to build on our successful model for implementing urgent care and clinical research, which pairs the rapid implementation of clinical trials with the utmost care and safety of our patients.”

In 2019, Elligo Health raised $20m in a Series C funding round to further boost physician and patient access to clinical trials using its Goes Direct approach and IntElligo Research Stack clinical technology.

Content from our partners
Africa’s last mile: Building viable vaccine supply chains
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide

Elligo Health Research CEO John Potthoff said: “Partnering with LCRA will allow Elligo to bring access for clinical research to additional ethnically diverse patients.

“Bringing more research as a care option to patients by expanding to even more diverse populations offers significant benefits for current patients and the future of cutting-edge medical treatments.”

In a separate development, connected healthcare solutions provider VivaLNK reported results from a survey, which found that 44% of all clinical research will deploy decentralised clinical trials within the coming 12 months.

The survey involved pharmaceutical, biotechnology and clinical research professionals, who provided their opinions on the current use of remote patient monitoring (RPM).

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU